$376 Million is the total value of Parkman Healthcare Partners LLC's 81 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UBX | Exit | UNITY BIOTECHNOLOGY INC | $0 | – | -404,092 | -100.0% | -0.04% | – |
| SIEN | Exit | SIENTRA INC | $0 | – | -373,586 | -100.0% | -0.07% | – |
| BLRX | Exit | BIOLINERX LTDsponsored ads | $0 | – | -288,852 | -100.0% | -0.08% | – |
| STIM | Exit | NEURONETICS INC | $0 | – | -85,866 | -100.0% | -0.08% | – |
| CDXS | Exit | CODEXIS INC | $0 | – | -105,319 | -100.0% | -0.18% | – |
| VRDN | Exit | VIRIDIAN THERAPEUTICS INC | $0 | – | -35,358 | -100.0% | -0.21% | – |
| HBIO | Exit | HARVARD BIOSCIENCE INC | $0 | – | -305,353 | -100.0% | -0.22% | – |
| ESTA | Exit | ESTABLISHMENT LABS HLDGS INC | $0 | – | -15,173 | -100.0% | -0.24% | – |
| Exit | PEPGEN INC | $0 | – | -100,000 | -100.0% | -0.26% | – | |
| XAIR | Exit | BEYOND AIR INC | $0 | – | -126,442 | -100.0% | -0.27% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -10,873 | -100.0% | -0.62% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -15,000 | -100.0% | -0.80% | – |
| Exit | IMAGO BIOSCIENCES INC | $0 | – | -189,193 | -100.0% | -0.81% | – | |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -242,600 | -100.0% | -0.88% | – |
| IRTC | Exit | IRHYTHM TECHNOLOGIES INC | $0 | – | -25,458 | -100.0% | -0.91% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -45,304 | -100.0% | -0.93% | – |
| APEN | Exit | APOLLO ENDOSURGERY INC | $0 | – | -657,690 | -100.0% | -1.03% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -42,961 | -100.0% | -1.04% | – |
| TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -7,500 | -100.0% | -1.08% | – |
| Exit | R1 RCM INC | $0 | – | -278,486 | -100.0% | -1.47% | – | |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -117,634 | -100.0% | -3.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEXCOM INC | 16 | Q3 2023 | 6.3% |
| ACLARIS THERAPEUTICS INC | 16 | Q3 2023 | 10.0% |
| XENON PHARMACEUTICALS INC | 16 | Q3 2023 | 3.3% |
| NATERA INC | 16 | Q3 2023 | 3.4% |
| AVID BIOSERVICES INC | 15 | Q3 2023 | 2.9% |
| SCHRODINGER INC | 15 | Q3 2023 | 4.2% |
| REPRO MED SYS INC | 15 | Q2 2023 | 2.0% |
| MANNKIND CORP | 15 | Q3 2023 | 1.6% |
| IQVIA HLDGS INC | 14 | Q1 2023 | 4.6% |
| INSULET CORP | 14 | Q3 2023 | 2.9% |
View Parkman Healthcare Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| PLUS THERAPEUTICS, INC. | February 13, 2023 | 583,467 | 1.7% |
View Parkman Healthcare Partners LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Parkman Healthcare Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.